These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16775388)

  • 1. No association between a functional NAD(P)H: quinone oxidoreductase gene polymorphism (Pro187Ser) and tardive dyskinesia.
    Hori H; Shinkai T; Matsumoto C; Ohmori O; Nakamura J
    Neuromolecular Med; 2006; 8(3):375-80. PubMed ID: 16775388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress in tardive dyskinesia: genetic association study and meta-analysis of NADPH quinine oxidoreductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genes.
    Zai CC; Tiwari AK; Basile V; de Luca V; Müller DJ; Voineskos AN; Remington G; Meltzer HY; Lieberman JA; Potkin SG; Kennedy JL
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):50-6. PubMed ID: 19778569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association analysis of NAD(P)Hratioquinone oxidoreductase (NQO1) Pro187Ser genetic polymorphism and tardive dyskinesia in patients with schizophrenia in Taiwan.
    Liou YJ; Wang YC; Lin CC; Bai YM; Lai IC; Liao DL; Chen JY
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):483-6. PubMed ID: 15836802
    [No Abstract]   [Full Text] [Related]  

  • 4. Quinone oxidoreductase (NQO1) gene polymorphism (609C/T) may be associated with tardive dyskinesia, but not with the development of schizophrenia.
    Pae CU; Yu HS; Kim JJ; Lee CU; Lee SJ; Jun TY; Lee C; Paik IH
    Int J Neuropsychopharmacol; 2004 Dec; 7(4):495-500. PubMed ID: 15151706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and manganese superoxide dismutase gene (MnSOD: Ala-9Val) polymorphisms on tardive dyskinesia in patients with schizophrenia.
    Pae CU
    Psychiatry Res; 2008 Dec; 161(3):336-8. PubMed ID: 18977034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association study between a functional glutathione S-transferase (GSTP1) gene polymorphism (Ile105Val) and tardive dyskinesia.
    Shinkai T; De Luca V; Hwang R; Matsumoto C; Hori H; Ohmori O; Remington G; Meltzer HY; Lieberman JA; Potkin SG; Nakamura J; Kennedy JL
    Neurosci Lett; 2005 Nov; 388(2):116-20. PubMed ID: 16039055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.
    Chao C; Zhang ZF; Berthiller J; Boffetta P; Hashibe M
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):979-87. PubMed ID: 16702380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAD(P)H: quinone oxidoreductase (NQO1) gene polymorphism and schizophrenia.
    Hori H; Ohmori O; Matsumoto C; Shinkai T; Nakamura J
    Psychiatry Res; 2003 Jun; 118(3):235-9. PubMed ID: 12834817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic association analysis of functional polymorphisms in the cytochrome P450 1A2 (CYP1A2) gene with tardive dyskinesia in Japanese patients with schizophrenia.
    Matsumoto C; Ohmori O; Shinkai T; Hori H; Nakamura J
    Psychiatr Genet; 2004 Dec; 14(4):209-13. PubMed ID: 15564895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.
    Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B
    Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NAD(P)H:quinone oxidoreductase 1 (NQO1) P187S polymorphism and prostate cancer risk in Caucasians.
    Stoehr CG; Nolte E; Wach S; Wieland WF; Hofstaedter F; Hartmann A; Stoehr R
    Int J Mol Sci; 2012; 13(9):10959-10969. PubMed ID: 23109831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association analysis of NAD(P)H:quinone oxidoreductase gene 609 C/T polymorphism with Alzheimer's disease.
    Wang B; Jin F; Xie Y; Tang Y; Kan R; Zheng C; Yang Z; Wang L
    Neurosci Lett; 2006 Dec; 409(3):179-81. PubMed ID: 17027152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinone oxidoreductase (NQO1) gene polymorphism may not confer a susceptibility to mood disorders.
    Pae CU; Yoon SJ; Patkar AA; Kim JJ; Lee C; Paik IH
    Psychiatry Res; 2007 Sep; 153(1):83-6. PubMed ID: 17644186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population.
    Pandith AA; Khan NP; Shah ZA; Shah AM; Wani SM; Siddiqi MA
    Biochem Genet; 2011 Aug; 49(7-8):417-26. PubMed ID: 21253823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association analyses between polymorphisms of the phase II detoxification enzymes (GSTM1, NQO1, NQO2) and alcohol withdrawal symptoms.
    Okubo T; Harada S; Higuchi S; Matsushita S
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):68S-71S. PubMed ID: 12960511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population.
    Sameer AS; Shah ZA; Syeed N; Rasool R; Afroze D; Siddiqi MA
    Asian Pac J Cancer Prev; 2010; 11(1):209-13. PubMed ID: 20593958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysis.
    Peng Q; Lu Y; Lao X; Chen Z; Li R; Sui J; Qin X; Li S
    Diagn Pathol; 2014 May; 9():100. PubMed ID: 24884893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No association between Helicobacter pylori seropositivity and ornithine decarboxylase (ODC) A317G polymorphism, and no modification by NAD(P)H:qinone oxidoreductase 1 (NQO1) C609T.
    Goto Y; Nishio K; Ishida Y; Kawai S; Osafune T; Naito M; Katsuda N; Hamajima N
    Nagoya J Med Sci; 2007 Jan; 69(1-2):17-22. PubMed ID: 17378176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A NAD(P)H:quinone oxidoreductase 1 polymorphism is a risk factor for human colon cancer.
    Begleiter A; Hewitt D; Maksymiuk AW; Ross DA; Bird RP
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2422-6. PubMed ID: 17164365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic association analysis of the glutathione peroxidase (GPX1) gene polymorphism (Pro197Leu) with tardive dyskinesia.
    Shinkai T; Müller DJ; De Luca V; Shaikh S; Matsumoto C; Hwang R; King N; Trakalo J; Potapova N; Zai G; Hori H; Ohmori O; Meltzer HY; Nakamura J; Kennedy JL
    Psychiatry Res; 2006 Feb; 141(2):123-8. PubMed ID: 16413612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.